Dechra Pharma selects Alison Platt as next chair
Dechra Pharmaceuticals
3,866.00p
08:01 16/01/24
Dechra Pharmaceuticals has selected Alison Platt to chair the board when Tony Rice steps down at the end of 2021.
FTSE 250
19,763.46
14:40 24/04/24
FTSE 350
4,432.18
14:40 24/04/24
FTSE All-Share
4,386.44
14:40 24/04/24
Pharmaceuticals & Biotechnology
21,972.86
14:40 24/04/24
Platt has been a non-executive director at Dechra since March 2020 and sits on the boards of Tesco and Spectrum. She is also chair of Legal & General Financial Advice.
Rice announced his retirement in September after five years as chairman of the veterinary pharmaceuticals group and will hand over to Platt on 31 December. Denise Goode, a non-executive director, has resigned and will leave the board at the end of November.
Ian Page, Dechra's chief executive, said: "Since joining us in 2020 Alison has gained a good understanding of Dechra and our culture. Her extensive leadership experience and skills will further enhance the team's capabilities. I would also like to acknowledge Tony's contribution to the development of the group. We wish him all the best."